These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1195205)

  • 1. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. B. Genetic effects. 2. Cytogenetic study.
    Awa AA
    J Radiat Res; 1975 Sep; 16 Suppl():75-81. PubMed ID: 1195205
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. G. Chromosome aberrations in somatic cells.
    Awa AA
    J Radiat Res; 1975 Sep; 16 Suppl():122-31. PubMed ID: 1195195
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH.
    Kodama Y; Nakamura N; Nakano M; Ohtaki K; Hamasaki K; Noda A
    Int J Radiat Biol; 2024; 100(8):1155-1164. PubMed ID: 38991111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki.
    Awa AA; Sofuni T; Honda T; Itoh M; Neriishi S; Otake M
    J Radiat Res; 1978 Jun; 19(2):126-40. PubMed ID: 712662
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. B. Genetic effects. 1. Early genetic surveys and mortality study.
    Kato H
    J Radiat Res; 1975 Sep; 16 Suppl():67-74. PubMed ID: 1195204
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. H. Cataracts.
    Dodo T
    J Radiat Res; 1975 Sep; 16 Suppl():132-7. PubMed ID: 1195196
    [No Abstract]   [Full Text] [Related]  

  • 8. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Chromosome abnormality in early entrants.
    Kamada N
    J Radiat Res; 1991 Mar; 32 Suppl():275-7. PubMed ID: 1762115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. F. Aging.
    Finch SC; Beebe GW
    J Radiat Res; 1975 Sep; 16 Suppl():108-21. PubMed ID: 1195193
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. The Japan Radiation Research Society Chiba. Japan, September, 1975].
    Gus'kova AK; Sadchikova EN
    Med Radiol (Mosk); 1977 Aug; 22(8):69-77. PubMed ID: 927066
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. D. Leukemia and related disorders.
    Ichimaru M; Ishimaru T
    J Radiat Res; 1975 Sep; 16 Suppl():89-96. PubMed ID: 1104825
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. A. Acute effects.
    Okita T
    J Radiat Res; 1975 Sep; 16 Suppl():49-66. PubMed ID: 1195203
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. E. Cancers other than leukemia.
    Beebe GW; Kato H
    J Radiat Res; 1975 Sep; 16 Suppl():97-107. PubMed ID: 1195207
    [No Abstract]   [Full Text] [Related]  

  • 16. [The present state of atomic bomb survivors, with special reference to biological late-effects of radiation].
    Kamada N
    Rinsho Byori; 2004 Mar; 52(3):217-22. PubMed ID: 15137319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of chromosome aberrations in atomic bomb survivors for dose assessment: studies at the Radiation Effects Research Foundation from 1968 to 1993.
    Awa A
    Stem Cells; 1997; 15 Suppl 2():163-73. PubMed ID: 9368301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic investigation of survivors of the atomic bombings of Hiroshima and Nagasaki.
    Bloom AD; Neriishi S; Kamada N; Iseki T; Keehn RJ
    Lancet; 1966 Sep; 2(7465):672-4. PubMed ID: 4162352
    [No Abstract]   [Full Text] [Related]  

  • 20. A chromosome study of 6-thioguanine-resistant mutants in T lymphocytes of Hiroshima atomic bomb survivors.
    Kodama Y; Hakoda M; Shimba H; Awa AA; Akiyama M
    Mutat Res; 1989 Sep; 227(1):31-8. PubMed ID: 2788814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.